Back to profiles

Will Rosellini

Dallas/Fort Worth Area

Turning bodies into cars, where parts become manufactured, replaced, remotely updated and enhanced, former minor leaguer with Arizona Diamondbacks, IP expert and entrepreneur who has returned money to investors from 2 company exits, life science CEO with 3 companies in progress,Investor in a number of life science companies via Rosellini Scientific, Pubco Board member with Audit and Compensation Committee experience

Request a Call

On-demand, expert advice.

Areas of Expertise

  • Capital formation

    I have raised nearly $50M in non-dilutive and at risk capital for medical device companies.

    • Finance
    • Other

Investing Profile

Investor Overview
4-7 investments
Invests $100,000 per company

My Interests

Health Sectors
Medical Devices


  • Co-Founder, Director and CEO

    Nuviant Medical, Inc. | December 2014 - Current

    Nuviant is developing implantable neurostimulation systems for the relief of various chronic diseases and disorders. Nuviant's first product, the Synapse™ system, has received the CE Mark for certain movement disorders. Nuviant intends to use the product in additional human clinical studies and prepare it for commercialization in select world markets. Nuviant Medical has produced and tested its device in accordance with FDA Good Manufacturing Practices in its 10,000 square foot state of the art cleanroom.

  • Member Board of Directors

    Marathon Patent Group | January 2013 - Current

    A provider of intellectual property services to clients ranging from individuals to Fortune 500 companies Chair the Audit Committee, participate as a member of Compensation Committee Provided insightful technology and strategy support to the executive team and CEO

  • Founding Partner

    Rosellini Scientific LLC | January 2005 - Current

    Incubator hedge fund operating as a family office, the enterprise has licensed/acquired IP, spun-out, formed JV's, done investments, acquisitions and mergers in a variety of technology industries